Mengyuan Ke is a Postdoctoral Research Fellow at Massachusetts General Hospital and Harvard Medical School (2025–present), where she develops advanced optical imaging/therapeutic technologies and quantitative analysis methods for clinical applications. Her work focuses on optical coherence tomography (OCT), imaging biomarkers, and translational approaches for cancer and neurodegenerative diseases. She completed her PhD at the Medical University of Vienna (2021–2025) in the Center for Medical Physics and Biomedical Engineering, where she worked at the interface of academia, clinical practice, and industry to develop medical imaging systems under regulatory frameworks. Prior to this, she worked at the Singapore Eye Research Institute (2019–2021), focusing on ocular disease research using OCT. She holds a Master of Science in Physics from the University of Waterloo (2016–2018), where her research focused on adaptive optics retinal imaging and wavefront aberrations in eye development. Her research interests include optical coherence imaging, biomedical signal processing, digital biomarkers, and the translation of imaging technologies into clinically impactful diagnostic tools.